Induced Pluripotent Stem Cell-Derived Red Blood Cells, Megakaryocytes, and Platelets: Progress and Challenges

Area of Science:

• Stem cell biology
• Hematology
• Regenerative medicine

Background:

• Human induced pluripotent stem cells (iPSCs) are a potential source for generating blood components for transfusion.
• Current protocols often mimic primitive hematopoiesis, but new progenitors offer pathways to definitive blood cells.

Purpose of the Study:

• To review progress and challenges in generating clinical-grade red blood cells and platelets from human iPSCs.
• To highlight the potential of iPSCs for transfusion support and other applications.

Main Methods:

• Review of scientific literature on iPSC differentiation protocols.
• Analysis of strategies for improving hematopoietic progenitor maturation and expansion.
• Evaluation of challenges in terminal differentiation and scalability.

Main Results:

• Identification of a hematopoietic progenitor mimicking the second wave of hematopoiesis, leading to definitive blood cells.
• Advancements in strategies for maturation and expansion of iPSC-derived red cells and platelets.
• Progress towards generating cells that can mature, enucleate, and proliferate to clinical scale.

Conclusions:

• Human iPSCs offer a renewable source for red blood cells and platelets, overcoming limitations of traditional sources.
• Major challenges include achieving terminal differentiation and scalability for clinical applications.
• iPSCs hold promise for transfusion products, rare blood types, reagents, and drug delivery systems.